Peptides DB
Research-centric peptide and protocol reference hub
Study 15 of 15PT-141 (Bremelanotide) literaturebiorxiv-preprint · Observational

Lifespan brain structural variation reveals shared organization across mental health conditions

This study highlights that structural brain deviations in various mental health conditions may follow a shared organizational pattern, but individual variability remains significant.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the pt-141 (bremelanotide) corpus
7
Preclinical
4
Observational · this one
0
Open-label
1
Randomised
3
Reviews

Summary and findings

This study examined brain structural variations in individuals with neurodevelopmental and psychiatric conditions compared to reference participants. A total of 10,135 individuals with various disorders and 11,998 reference participants were analyzed. The findings suggest that structural deviations in the brain are organized along specific axes that reflect connectome organization and vary across diagnoses.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.

Abstract

The authors’ words, as biorxiv-preprint supplied them

Elucidating the neurobiological basis of neurodevelopmental and psychiatric conditions (NDPCs) remains challenging because brain alterations vary within diagnoses and overlap across them. Whether diverse alterations follow a systematic organization that may reflect shared vulnerabilities remains unknown. Here, we assembled 10,135 individuals with schizophrenia, autism, bipolar, obsessive-compulsive, generalized anxiety, and major depressive disorders, and 11,998 reference participants across six continents through the ENIGMA consortium. Using normative modeling, we quantified individual deviations in cortical thickness, surface area, and subcortical volumes relative to lifespan reference trajectories (5 to 80 years). We show that structural deviations converged along cortical axes reflecting connectome organization, maturation, and cytoarchitectonic diversity. These axes mirrored typical population variation, but their expression differed across diagnoses and partly scaled with symptom severity. Even rare and highly individualized extreme deviations followed this organization, concentrating in densely connected regions. Finally, brain structural deviations overlapped substantially across diagnoses, while differences between them increased toward the association cortex. Together, we provide large-scale evidence that structural deviations across NDPCs are systematically constrained by the brain’s intrinsic architecture. This shared organization provides a framework for reconciling individual variability with transdiagnostic similarities and motivates an integrative, systems-level understanding of mental health.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the PT-141 (Bremelanotide) corpus

DSexual arousal: Sex matters.Nature · 2017ASafety, tolerability, and pharmacokinetics/-dynamics of the dipeptidyl peptidase 3-inhibiting antibody Procizumab in a first-in-human trial.mAbs · 2026 · Terminal elimination half-life of 24 h (3 mg/kg), 34 h (6 mg/kg), and 53 h (12 mg/kg).HumanCPreclinical safety evaluation of the dipeptidyl peptidase 3 inhibiting antibody Procizumab in rodents and non-human primates.mAbs · 2026 · 150 mg/kg PCZ in mice, n=126; 350 mg/kg PCZ in monkeys, n=10.AnimalBRisk stratification for in-hospital mortality in sepsis-associated acute kidney injury patients receiving continuous renal replacement therapy: an interpretable, externally validated machine learning study.Renal failure · 2026 · AUC of 0.890 in training cohort, n=1217.HumanDComprehensive characterization of bremelanotide acetate and its degradants by LC-HRMS/MS and predicting epimerization through computational modelling.Analytical methods : advancing methods and applications · 2026 · Coefficient of determination (r²) of 0.9993 over the concentration range of 25-150 µg mL-1.reviewCIncorporation of Three Extracyclic Arginine Residues into a Melanocortin Macrocyclic Agonist (c[Pro-His-DPhe-Arg-Trp-Dap-Lys(Arg-Arg-Arg-Ac)-DPro]) Decreases Food Intake When Administered Intrathecally or Subcutaneously Compared to a Macrocyclic Ligand Lacking Extracyclic Arginine Residues (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro)].ACS pharmacology & translational science · 2024 · n=30 · Not reported in abstract.Animal